Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis

Fig. 5

Characteristics of prognostic genes. a Distribution map of patients in high and low risk groups based on risk score; b Survival status map of patients in high and low risk groups (left side of the dotted line, low risk group; right side of the dotted line, high risk group); c Heatmap of DR-DEGs associated with prognostic features of endometrial cancer

Back to article page